Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Expensify
EXFY
$176M
| $2.9M | ﹤0.01% |
1,118,200
+180,100
| +19% | +$460K |
|
|
PVBC
1877
DELISTED
Provident Bancorp
PVBC
| $2.89M | ﹤0.01% |
231,672
+101,200
| +78% | +$1.15M |
|
1878
iShares US Financials ETF
IYF
$4.67B
| $2.89M | ﹤0.01% |
+23,900
| New | +$2.69M |
|
|
CTEV
1879
Claritev Corp
CTEV
$387M
| $2.89M | ﹤0.01% |
63,963
+11,348
| +22% | +$326K |
|
1880
V2X
VVX
$2.83B
| $2.88M | ﹤0.01% |
59,400
-2,500
| -4% | -$119K |
|
|
ETWO
1881
DELISTED
E2open Parent Holdings
ETWO
| $2.88M | ﹤0.01% |
891,600
+732,800
| +461% | +$1.93M |
|
|
SRTA
1882
Strata Critical Medical Inc
SRTA
$434M
| $2.87M | ﹤0.01% |
711,686
+121,647
| +21% | +$396K |
|
1883
InfuSystem Holdings
INFU
$184M
| $2.87M | ﹤0.01% |
459,609
+124,994
| +37% | +$691K |
|
1884
CION Investment
CION
$297M
| $2.86M | ﹤0.01% |
298,700
-278,600
| -48% | -$2.65M |
|
|
FIRY
1885
Firy Inc
FIRY
$148M
| $2.85M | ﹤0.01% |
418,225
+1,700
| +0.4% | +$9.44K |
|
1886
Kodiak Sciences
KOD
$2.6B
| $2.85M | ﹤0.01% |
764,137
+61,537
| +9% | +$218K |
|
1887
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
| $2.85M | ﹤0.01% |
55,400
+48,900
| +752% | +$2.47M |
|
1888
Korn Ferry
KFY
$4.18B
| $2.85M | ﹤0.01% |
+38,800
| New | +$2.58M |
|
1889
Liberty Latin America Class A
LILA
$1.64B
| $2.85M | ﹤0.01% |
686,541
-66,768
| -9% | -$242K |
|
1890
Camtek
CAMT
$6.18B
| $2.84M | ﹤0.01% |
33,640
-10,900
| -24% | -$735K |
|
1891
National Health Investors
NHI
$3.72B
| $2.84M | ﹤0.01% |
+40,500
| New | +$2.97M |
|
1892
Kyndryl
KD
$2.99B
| $2.84M | ﹤0.01% |
67,600
-551,767
| -89% | -$20M |
|
1893
Viemed Healthcare
VMD
$447M
| $2.84M | ﹤0.01% |
410,300
+25,900
| +7% | +$176K |
|
|
CRON
1894
Cronos Group
CRON
$1.06B
| $2.83M | ﹤0.01% |
1,481,749
+346,096
| +30% | +$656K |
|
1895
NCR Atleos
NATL
$3.47B
| $2.82M | ﹤0.01% |
98,800
+5,900
| +6% | +$159K |
|
1896
Alerus Financial
ALRS
$831M
| $2.81M | ﹤0.01% |
129,975
+3,315
| +3% | +$66.3K |
|
1897
Century Aluminum
CENX
$4.43B
| $2.8M | ﹤0.01% |
+155,599
| New | +$2.64M |
|
1898
Enpro
NPO
$6.63B
| $2.8M | ﹤0.01% |
+14,600
| New | +$2.5M |
|
1899
Pangaea Logistics
PANL
$498M
| $2.79M | ﹤0.01% |
594,100
-2,986
| -0.5% | -$13.3K |
|
1900
iShares ESG Aware MSCI EM ETF
ESGE
$6.58B
| $2.79M | ﹤0.01% |
71,200
+64,500
| +963% | +$2.34M |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.